https://www.selleckchem.com/pr....oducts/gsk1120212-jt
It is well-established that adults with polycystic ovary syndrome (PCOS) have increased prevalence of several cardiometabolic risk factors, including obesity, insulin resistance, type 2 diabetes mellitus and dyslipidemia. Accumulating data suggest that these risk factors are already present in adolescence in patients with PCOS. This has major implications for the management of this population, since the timely identification of these risk factors is essential for preventing cardiovascular disease in adulthood. The present r
Like
Comment
Share
